Holen Sie sich die Stockscreener-App
39.40
0.97%
0.38
Handel nachbörslich:
39.40
Schlusskurs vom Vortag:
$39.02
Offen:
$38.26
24-Stunden-Volumen:
1.05M
Relative Volume:
0.89
Marktkapitalisierung:
$9.01B
Einnahmen:
$5.30B
Nettoeinkommen (Verlust:
$-624.00M
KGV:
-12.84
EPS:
-3.0692
Netto-Cashflow:
$42.00M
1W Leistung:
-3.15%
1M Leistung:
+1.97%
6M Leistung:
-18.31%
1J Leistung:
-46.79%
1-Tages-Spanne:
$38.26
$39.55
1-Wochen-Bereich:
$37.72
$41.83
52-Wochen-Spanne:
$36.66
$74.84
Lineage Inc Stock (LINE) Company Profile
Firmenname
Lineage Inc
Sektor
Branche
Telefon
(800) 678-7271
Adresse
46500 HUMBOLDT DRIVE, NOVI
Vergleichen Sie LINE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LINE
Lineage Inc
|
39.40 | 8.93B | 5.30B | -624.00M | 42.00M | -3.0692 |
|
PLD
Prologis Inc
|
124.09 | 115.39B | 8.74B | 3.43B | 4.25B | 3.4347 |
|
PSA
Public Storage
|
278.56 | 49.28B | 4.75B | 1.82B | 2.82B | 9.1652 |
|
EXR
Extra Space Storage Inc
|
133.54 | 28.61B | 3.31B | 1.03B | 1.74B | 4.6014 |
|
REXR
Rexford Industrial Realty Inc
|
41.32 | 9.62B | 903.94M | 275.97M | 94.31M | 1.23 |
|
EGP
Eastgroup Properties Inc
|
174.53 | 9.37B | 679.77M | 236.60M | 385.49M | 4.6371 |
Lineage Inc Stock (LINE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-07-01 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-06-23 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-06-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-06-12 | Herabstufung | BNP Paribas Exane | Neutral → Underperform |
| 2025-05-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-04-10 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-28 | Eingeleitet | Citigroup | Neutral |
| 2025-01-14 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2024-12-20 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-09-18 | Eingeleitet | CapitalOne | Overweight |
| 2024-09-16 | Eingeleitet | CapitalOne | Overweight |
| 2024-08-19 | Eingeleitet | Deutsche Bank | Hold |
| 2024-08-19 | Eingeleitet | Evercore ISI | In-line |
| 2024-08-19 | Eingeleitet | Goldman | Buy |
| 2024-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2024-08-19 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-19 | Eingeleitet | Mizuho | Neutral |
| 2024-08-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-08-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-08-19 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-19 | Eingeleitet | Truist | Buy |
| 2024-08-19 | Eingeleitet | UBS | Neutral |
| 2024-08-19 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Lineage Inc Aktie (LINE) Neueste Nachrichten
What earnings revisions data tells us about Lineage Inc.Weekly Profit Report & Fast Exit and Entry Strategy Plans - newser.com
How to recover losses in Lineage Inc. stockCPI Data & High Return Stock Watch Alerts - newser.com
How Lineage Inc. stock performs in interest rate cycles2025 Key Lessons & AI Forecasted Entry and Exit Points - newser.com
Will Lineage Inc. stock benefit from upcoming earnings reportsLayoff News & Scalable Portfolio Growth Methods - newser.com
Will a bounce in Lineage Inc. offer an exitMarket Activity Recap & Safe Entry Trade Reports - newser.com
What margin trends mean for Lineage Inc. stockJuly 2025 Summary & Safe Capital Preservation Plans - newser.com
Lineage (LINE): Valuation in Focus as Analyst Outlook and Earnings Anticipation Shape Investor Sentiment - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Encourages Lineage, Inc. (LINE) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025 - Investing News Network
When is the best time to exit Lineage Inc.2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com
Is Lineage Cell Therapeutics Inc. stock cheap by valuation metrics2025 Growth vs Value & Technical Pattern Recognition Alerts - newser.com
Tools to assess Lineage Cell Therapeutics Inc.’s risk profilePortfolio Gains Summary & Daily Price Action Insights - newser.com
Why analysts upgrade Lineage Inc. stock2025 Key Lessons & AI Forecasted Entry and Exit Points - newser.com
Volume spikes in Lineage Inc. stock – what they mean2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com
Ethic Inc. Acquires New Holdings in Lineage, Inc. $LINE - MarketBeat
How Lineage Cell Therapeutics Inc. stock reacts to Fed tighteningWeekly Risk Summary & AI Optimized Trading Strategy Guides - newser.com
Can Lineage Inc. recover in the next quarterWeekly Profit Recap & Weekly Breakout Watchlists - newser.com
Using R and stats models for Lineage Inc. forecastingBond Market & Fast Entry Momentum Trade Alerts - newser.com
How institutional buying supports Lineage Cell Therapeutics Inc. stock2025 Retail Activity & Growth Focused Investment Plans - Fundação Cultural do Pará
How Lineage Inc. stock compares to growth peers2025 Key Highlights & Growth Focused Entry Reports - Fundação Cultural do Pará
How resilient is Lineage Inc. stock in market downturnsJuly 2025 Setups & Free High Return Stock Watch Alerts - Fundação Cultural do Pará
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Shareholders to Connect - ACCESS Newswire
Barclays Lowers the PT on Lineage, Inc. (LINE), Keeps a Buy Rating - MSN
Is Lineage Cell Therapeutics Inc. stock a momentum leaderPortfolio Return Report & AI Enhanced Execution Alerts - newser.com
Is Lineage Cell Therapeutics Inc. stock a fit for income portfoliosRecession Risk & Reliable Breakout Stock Forecasts - Fundação Cultural do Pará
Is Lineage Cell Therapeutics Inc. stock a top pick in earnings seasonMarket Sentiment Report & Community Verified Trade Alerts - newser.com
Will Lineage Cell Therapeutics Inc. stock benefit from commodity pricesTake Profit & Free Safe Entry Trade Signal Reports - Fundação Cultural do Pará
Will Lineage Inc. stock deliver better than expected guidanceQuarterly Growth Report & Low Drawdown Trading Techniques - Fundação Cultural do Pará
Lineage’s Cold-Storage Empire Struggles To Defrost Its Stock Price - Finimize
Will Lineage Inc. stock benefit from infrastructure spendingWatch List & Safe Entry Point Identification - newser.com
Chilton Capital Management LLC Purchases New Shares in Lineage, Inc. $LINE - MarketBeat
Why hedge funds are buying Lineage Cell Therapeutics Inc. stockJuly 2025 Macro Moves & Capital Protection Trading Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Investors to Connect - ACCESS Newswire
Finanzdaten der Lineage Inc-Aktie (LINE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lineage Inc-Aktie (LINE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Thattai Sudarsan V | See Remarks |
Aug 08 '25 |
Buy |
42.45 |
3,563 |
151,238 |
7,983 |
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN |
Aug 08 '25 |
Buy |
42.28 |
23,540 |
995,216 |
62,323 |
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN |
May 09 '25 |
Buy |
45.63 |
11,050 |
504,187 |
38,783 |
| Forste Adam Matthew Schwartz | CO-EXECUTIVE CHAIRMAN |
May 08 '25 |
Buy |
44.93 |
10,949 |
491,921 |
35,266 |
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN |
May 06 '25 |
Buy |
43.75 |
11,500 |
503,074 |
27,733 |
| Thattai Sudarsan V | See Remarks |
May 05 '25 |
Buy |
45.23 |
4,420 |
199,908 |
4,420 |
| Forste Adam Matthew Schwartz | CO-EXECUTIVE CHAIRMAN |
Feb 28 '25 |
Buy |
60.50 |
24,317 |
1,471,144 |
24,317 |
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN |
Feb 28 '25 |
Buy |
60.51 |
16,233 |
982,229 |
16,233 |
0.64%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):